Daily digest · Wed · 7 Oct 2026

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.

🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic

Hematologic malignancies

[42838070] · MK-4002, a B-cell maturation antigen-targeting T-cell engager, in relapsed or refract · 7/10 · Taking safety and activity results together, a target dose of 12 mg was identified as the preliminary RP2D.

Early cancer detection

[42838765] · Efficacy of artificial intelligence in detecting precancerous lesions among a colorec · 9/10 · CONCLUSIONS: CADe-assisted colonoscopy did not improve ADR or AADR in a CRC organized screening population undergoing su [42835688] · Cerebrospinal fluid circulating tumor DNA profiling in central nervous system metasta · 7/10 · CONCLUSIONS: These preliminary findings indicate that CSF ctDNA can provide a sensitive, compartment-specific molecular [42835603] · A cfDNA fragmentomics-based machine learning model for predicting treatment response · 7/10 · Fragmentia-AI Response is a mutation-independent cfDNA fragmentomics model that showed reproducible discrimination of pa [42838663] · Superhydrophobic micro-structural substrate for renal cell carcinoma detection using · 7/10 · The substrate confined the urine droplet during drying, improved deposit uniformity, and enhanced LIBS measurement repea [42835240] · Decomposition-driven biomarker identification enhances non-invasive early cancer dete · 7/10 · This approach demonstrates that cancer-specific signals can be recovered at the component level, enabling the identifica [42838738] · Short-term risk prediction model for pancreatic cancer in type 2 diabetes: developmen · 7/10 · CONCLUSION: The STOP-DM model provides a practical approach to stratify pancreatic cancer risk and deliver targeted scre [42838324] · Breast cancer screening based on clinical breast examination performed by community h · 6/10 · https://ensaiosclinicos.gov.br/rg/RBR-39vm2nd.

Precision oncology and genomic medicine

[42836855] · Dapagliflozin for attenuating early anthracycline-associated cardiac changes (DAPA-AI · 8/10 · These findings suggest that dapagliflozin may help attenuate early anthracycline-associated cardiac changes, although la

Novel therapeutics: immunotherapy, CAR-T, targeted therapy

[42838469] · The Efficacy of Immune-checkpoint Inhibitors in Combination with Definitive Chemoradi · 8/10 · These findings support a promising role for this strategy, but the current evidence is limited by non-randomized study d

Rare diseases with high unmet need

[42835816] · Effectiveness of early initiation of idursulfase in infants and very young children w · 8/10 · GLMM analyses showed that, compared with their older siblings, patients who initiated ERT aged ≤12 months had better cli [42836106] · Systematic Literature Review of the Efficacy and Safety of Treatments in Congenital T · 8/10 · CONCLUSION: The available evidence highlights the persistent disease burden of cTTP, with patients experiencing acute ev

🟢⚪ STANDARD (5-7) — Top by Topic

Hematologic malignancies [42835577] · CPX-351 plus gemtuzumab ozogamicin in relapsed or refractory acute myeloid leukemia a · 6/10 · Treatment Innovation [42835289] · Single-cell sequencing reveals transcriptional and immunogenetic diversity in stereot · 6/10 · Treatment Innovation [42836697] · Redefining leptomeningeal metastasis in non-small cell lung cancer: From terminal com · 6/10 · Treatment Innovation [42838489] · Ultrasound of the salivary glands in Sjögren's syndrome: a narrative review of its di · 6/10 · Treatment Innovation [42838444] · Impact on renal function, tumor volume, and complications of transarterial embolizati · 6/10 · Treatment Innovation

Early cancer detection [42835427] · Endometrial thickness and cancer risk in asymptomatic postmenopausal women: Defining · 7/10 · Early Detection [42838603] · 5-year survival rate and determinants of decreased survival among patients with breas · 7/10 · Early Detection [42838239] · Pulmonary arterial volume and mortality in smokers without chronic obstructive pulmon · 7/10 · Early Detection [42835965] · Beyond variant detection: Mismatch repair gene alterations in plasma cell-free DNA fr · 6/10 · Early Detection [42838467] · The Impact of the Tumor Microenvironment on Immune Checkpoint Inhibitor Resistance in · 6/10 · Early Detection

AI/ML in clinical diagnostics and imaging [42838512] · Artificial intelligence-powered renal pathology for glomerular disease classification · 7/10 · Diagnostics [42835309] · Prediction models for endometriosis-associated ovarian malignancy: A systematic revie · 7/10 · Diagnostics [42836247] · Explainable Case-based Diagnosis and Risk Prediction in Oncology · 6/10 · Diagnostics [42836351] · Deep learning-based segmentation of non-perfused volume after magnetic resonance guid · 6/10 · Diagnostics [42835896] · Clinical evaluation of three deep learning contouring models for head and neck organs · 6/10 · Diagnostics

Precision oncology and genomic medicine [42836673] · Targeting RAS in pancreatic cancer · 7/10 · Genomics/Precision Medicine [42835690] · Correlation of high PRDX4 expression with poor prognosis in patients with ESCA: Bioin · 6/10 · Genomics/Precision Medicine [42838832] · Brain Tumor Vaccines: Next Steps · 6/10 · Genomics/Precision Medicine

Novel therapeutics: immunotherapy, CAR-T, targeted therapy [42838253] · Reconciling Conflicting Evidence on Peri-Immune Checkpoint Inhibitor COVID-19 mRNA Va · 7/10 · Treatment Innovation

Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk [42835607] · Age-dependent association of thyroid peroxidase antibodies with incident cardiovascul · 7/10 · Prevention [42835576] · Autoimmune disorders and cardiovascular disease: a matched cross-sectional analysis o · 7/10 · Prevention [42838835] · Early diabetes education and long-term cardiovascular outcomes among adults with newl · 7/10 · Prevention [42838799] · Major Adverse Cardiovascular Events in Men with High-risk Localized or Metastatic Pro · 7/10 · Prevention [42835958] · Early-onset atherosclerotic cardiovascular disease in young adults: Lifestyle, enviro · 6/10 · Prevention

Aging, longevity, and population health [42836600] · Not All Pain Is Equal: Lower Extremity Pain and Longitudinal Fall Risk in Older Adult · 7/10 · Public Health [42834886] · Risk of infection in ocrelizumab-treated adults with multiple sclerosis aged 55 years · 7/10 · Public Health [42838779] · Association between religious and spiritual engagement and sleep disturbance among ol · 7/10 · Public Health [42838711] · Six-year clinical course of depressive and anxiety disorders: analysis by age · 7/10 · Public Health [42838517] · Advanced paternal age affects miscarriages and live birth outcomes in oocyte donation · 7/10 · Public Health

Rare diseases with high unmet need [42835666] · Clinical immunogenicity in rAAV gene therapy: Insights and implications · 7/10 · Drug Development [42834625] · Intrahepatic Tissue-Resident CD8+ T-Cell Programmes Associate With Fibrosis and Local · 7/10 · Drug Development [42837612] · Diagnosing primary immunodeficiencies using protein-based screening assays · 7/10 · Drug Development [42834411] · Clinical management of metachromatic leukodystrophy cases identified in the German an · 7/10 · Drug Development [42837706] · Spatiotemporal heterogeneity of immune cells in knee osteoarthritis: Cytokine actions · 7/10 · Drug Development

💡 UNSOLICITED FINDS

[42838637] · Quality in Lung Cancer Surgery: A Structure-Process-Outcome Perspective · 6/10 · Outcomes extend beyond mortality to oncologic results and patient-centered measures. [42838636] · Designing Thoracic Surgical Care That Works for All: A Quality Improvement Approach t · 6/10 · Cumulative delays and geographic maldistribution of thoracic surgeons further exacerbate outcome gap [42836833] · Prenatal diagnosis and postnatal outcomes of foetal situs abnormalities: a single ter · 5/10 · However, an exploratory analysis showed that narrowing or blockage of blood flow leaving the right s [42835905] · Cancer risk perception among family members of patients with digestive tract cancer a · 5/10 · These findings support appropriately calibrated risk communication and guideline-based prevention co [42838662] · SERS sensing platform based on MIL-100(Fe)@AgNPs for norepinephrine/adenosine monitor · 5/10 · It offered comparable diagnostic accuracy to conventional mass spectrometry while significantly redu

📊 TODAY'S BREAKDOWN

By research category:

Early Detection: 12
Treatment Innovation: 8
Drug Development: 7
Prevention: 6
Diagnostics: 5
Public Health: 5
Genomics/Precision Medicine: 4
Other: 4 By evidence maturity:
Exploratory: 25
Validated: 24
Potentially Practice-Changing: 2 By watchlist topic (reviewed / retained / highest score):
Hematologic malignancies: 15 reviewed / 15 retained / best 7/10
CBC-based diagnostics and machine learning in hematology: 0 reviewed / 0 retained / best 0/10
Early cancer detection: 15 reviewed / 14 retained / best 9/10
AI/ML in clinical diagnostics and imaging: 15 reviewed / 14 retained / best 7/10
Precision oncology and genomic medicine: 15 reviewed / 15 retained / best 8/10
Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 15 retained / best 8/10
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 15 reviewed / 15 retained / best 8/10
Aging, longevity, and population health: 15 reviewed / 15 retained / best 7/10
Rare diseases with high unmet need: 13 reviewed / 12 retained / best 8/10
Sentinel: 10 reviewed / 8 retained / best 6/10 By source type: peer_reviewed 51 | preprint 0

Topics with zero 8+ articles this run:

CBC-based diagnostics and machine learning in hematology (best: 0/10)
AI/ML in clinical diagnostics and imaging (best: 7/10)
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk (best: 8/10)
Aging, longevity, and population health (best: 7/10)

🔧 RUN NOTES

CRDT window: 2026-10-06T09:00:00Z → 2026-10-07T09:00:00Z (1 day, no expansion needed: ≥5 relevant records found)
CBC-based diagnostics topic: Zero results from both primary and fallback queries in this window. Coverage recorded as complete (0 candidates).
PMID 31536183 (Rare diseases topic): EFetch returned no data; classified from ESummary title metadata at title-only conservative cap.
7 post-hoc scoring corrections applied: 42838835 (9→7, EHR cohort), 42838926 (8→4, small exercise RCT), 42835321 (8→6, workflow optimization), 42835503 (8→6, registry), 42838444 (8→6, meta-analysis low relevance), 42836712 (8→5, JACIE admin paper, NEAR_TERM flag removed), 42838800 (3→2, title-only letter, EARLY_CANCER_DETECTION flag removed).
Sentinel scan: 183 ESearch hits → 10 reviewed; 8 articles were unsolicited finds (matched sentinel but not primary watchlist topics).
Total unique PMIDs: 112 retrieved, 111 with full abstract (EFetch), 1 title-only.
All 51 retained articles passed schema validation. Articles sorted strictly by triage_score descending.